BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1402982)

  • 1. Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.
    Onofrj M; Curatola L; Ferracci F; Fulgente T
    J Neurol Neurosurg Psychiatry; 1992 Sep; 55(9):852-3. PubMed ID: 1402982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of HLA-DR2, DQw1 negative post-traumatic narcolepsy].
    Maeda M; Tamaoka A; Hayashi A; Mizusawa H; Shoji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):811-3. PubMed ID: 8777810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA DR2 in narcolepsy with sleep-onset REM periods but not cataplexy.
    Rosenthal L; Roehrs TA; Hayashi H; Zorick FJ; Wittig RM; Rosenthal J; Roth T
    Biol Psychiatry; 1991 Oct; 30(8):830-6. PubMed ID: 1751625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of HLA-DR2-negative hypersomnia manifesting sleep-onset rapid eye movement periods in the multiple sleep latency test.
    Yoshida Y; Kuroda K; Mandai M; Satani S; Emura N; Ueda S; Matsumura H; Yoneda H
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):295-7. PubMed ID: 10459716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR2 negative narcolepsy in Australian Caucasians: clinical features, serology and sequence specific oligonucleotide typing.
    Reutens DC; Haddad AP; Cantwell L; Berkovic SF
    J Neurol Sci; 1992 Nov; 113(1):26-30. PubMed ID: 1469452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR2-positive monozygotic twins discordant for narcolepsy.
    Pollmächer T; Schulz H; Geisler P; Kiss E; Albert ED; Schwarzfischer F
    Sleep; 1990 Aug; 13(4):336-43. PubMed ID: 2267476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of narcolepsy in preteenaged children.
    Kotagal S; Hartse KM; Walsh JK
    Pediatrics; 1990 Feb; 85(2):205-9. PubMed ID: 2296508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level.
    Dauvilliers Y; Abril B; Charif M; Quittet P; Bauchet L; Carlander B; Touchon J
    Neurology; 2007 Sep; 69(12):1300-1. PubMed ID: 17875919
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
    Mignot E; Hayduk R; Black J; Grumet FC; Guilleminault C
    Sleep; 1997 Nov; 20(11):1012-20. PubMed ID: 9456467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the occurrence of HLA DR2 in 124 narcoleptics: clinical aspects.
    Roth B; Nevsímalová S; Sonka K; Docekal P; Schulz H; Geisler P; Pollmächer T; Andreas-Zietz A; Keller E; Scholz S
    Schweiz Arch Neurol Psychiatr (1985); 1988; 139(4):41-51. PubMed ID: 2459761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies.
    Matsuki K; Honda Y; Juji T
    Tissue Antigens; 1987 Oct; 30(4):155-60. PubMed ID: 3120349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Narcolepsy].
    Domínguez Ortega L
    An Med Interna; 1992 May; 9(5):211-3. PubMed ID: 1504200
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome.
    Stahl SM; Layzer RB; Aminoff MJ; Townsend JJ; Feldon S
    Neurology; 1980 Oct; 30(10):1115-8. PubMed ID: 6252510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy associated with lesions of the diencephalon.
    Aldrich MS; Naylor MW
    Neurology; 1989 Nov; 39(11):1505-8. PubMed ID: 2812331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic ambiguities in a case of post-traumatic narcolepsy with cataplexy.
    Bruck D; Broughton RJ
    Brain Inj; 2004 Mar; 18(3):321-6. PubMed ID: 14726290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An etiology of narcolepsy-cataplexy and a proposed cataplexy neuromechanism.
    Scrima L
    Int J Neurosci; 1981; 15(1-2):69-86. PubMed ID: 7287329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls.
    Hinze-Selch D; Wetter TC; Zhang Y; Lu HC; Albert ED; Mullington J; Wekerle H; Holsboer F; Pollmächer T
    Neurology; 1998 Apr; 50(4):1149-52. PubMed ID: 9566413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology of narcolepsy-cataplexy syndrome.
    Aldrich MS
    Int J Neurol; 1991-1992; 25-26():29-40. PubMed ID: 11980061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in electroencephalographic findings among categories of narcolepsy-spectrum disorders.
    Sasai-Sakuma T; Inoue Y
    Sleep Med; 2015 Aug; 16(8):999-1005. PubMed ID: 26026626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.